Strategies for recombinant production of antimicrobial peptides with pharmacological potential
- 2 April 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Clinical Pharmacology
- Vol. 13 (4), 367-390
- https://doi.org/10.1080/17512433.2020.1764347
Abstract
Introduction: The need to develop new drugs for the control of pathogenic microorganisms has redoubled efforts to prospect for antimicrobial peptides (AMPs) from natural sources and to characterize its structure and function. These molecules present a broad spectrum of action against different microorganisms and frequently present promiscuous action, with anticancer and immunomodulatory activities. Furthermore, AMPs can be used as biopharmaceuticals in the treatment of hospital-acquired infections and other serious diseases with relevant social and economic impacts. Areas covered: The low yield and the therefore difficult extraction and purification process in AMPs are problems that limit their industrial application and scientific research. Thus, optimized heterologous expression systems were developed to significantly boost AMP yields, allow high efficiency in purification and structural optimization for the increase of therapeutic activity. Expert opinion: This review provides an update on recent developments in the recombinant production of ribosomal and non-ribosomal synthesis of AMPs and on strategies to increase the expression of genes encoding AMPs at the transcriptional and translational levels and regulation of the post-translational modifications. Moreover, there are detailed reports of AMPs that have already reached marketable status or are in the pipeline under advanced stages of preclinical testing.Keywords
Funding Information
- Coordination of Improvement of Higher Education Personnel (2018-1070)
- Coordination of Improvement of Higher Education Personnel (11117-2020)
- Coordination of Improvement of Higher Education Personnel (1456-2020)
- Coordination of Improvement of Higher Education Personnel (2017-1000)
This publication has 304 references indexed in Scilit:
- Overproduction of recombinant proteins in plantsPlant Science, 2012
- Performance and long-term stability of the barley hordothionin gene in multiple transgenic apple linesTransgenic Research, 2011
- Cloning large natural product gene clusters from the environment: Piecing environmental DNA gene clusters back together with TARPeptide Science, 2010
- Structure−Activity Relationships of Polymyxin AntibioticsJournal of Medicinal Chemistry, 2009
- Escherichia coli Allows Efficient Modular Incorporation of Newly Isolated Quinomycin Biosynthetic Enzyme into Echinomycin Biosynthetic Pathway for Rational Design and Synthesis of Potent Antibiotic Unnatural Natural ProductJournal of the American Chemical Society, 2009
- Pharmacodynamic activity of the lantibiotic MU1140International Journal of Antimicrobial Agents, 2009
- Baculovirus as versatile vectors for protein expression in insect and mammalian cellsNature Biotechnology, 2005
- The humanization of N-glycosylation pathways in yeastNature Reviews Microbiology, 2005
- Expression of heterologous proteins inPichia pastoris: a useful experimental tool in protein engineering and productionJournal of Molecular Recognition, 2004
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004